SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001172661-08-000146
Filing Date
2008-02-14
Accepted
2008-02-14 11:26:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G HOLDINGS REPORT bcrx0208.txt SC 13G 10782
  Complete submission text file 0001172661-08-000146.txt   12649
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-44055 | Film No.: 08610039
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 767 3RD AVENUE 30TH FLOOR NEW YORK NY 10017
Business Address 767 3RD AVENUE 30TH FLOOR NEW YORK NY 10017 2126845700
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13G